Breastfeeding Initiation Rates After Non-Pharmacological Pain Management During Neonatal Circumcision: A Systematic Review
Keywords:
Neonatal circumcision; breastfeeding; pain management; sucrose; skin-to-skin contactAbstract
Introduction: Neonatal circumcision is a common painful procedure. Untreated pain disrupts breastfeeding initiation and bonding. Non-pharmacological interventions (sucrose, non-nutritive sucking, skin-to-skin contact, facilitated tucking) are recommended but their comparative effectiveness for promoting breastfeeding post-procedure is unclear.
Methods: We searched PubMed, PsycINFO, and Embase for RCTs of non-pharmacological pain interventions during male neonatal circumcision (≤30 days old) reporting breastfeeding initiation within 2 hours post-procedure. Comparator: placebo or usual care (lidocaine alone). Outcome: successful latch and suckling duration ≥5 minutes. Meta-analysis used Mantel-Haenszel fixed-effects model.
Results: Nine RCTs (n=847 neonates) met criteria. Combination interventions (sucrose + non-nutritive sucking + skin-to-skin) significantly improved breastfeeding initiation compared to control (74% vs. 48%; RR 1.54, 95% CI 1.31–1.81). Sucrose alone was superior to placebo (RR 1.28, 95% CI 1.09–1.50) but inferior to combination (p=0.02). Skin-to-skin alone had the smallest effect (RR 1.12, 95% CI 0.95–1.33). Pain scores (NIPS) inversely correlated with breastfeeding success (r=-0.68).
Discussion: Multimodal non-pharmacological pain management yields the highest breastfeeding initiation rates after circumcision. The dose-response relationship suggests cumulative analgesic effect. Limitations include small sample sizes and variable circumcision techniques (Gomco vs. Mogen clamp).
Conclusions: To optimize breastfeeding after neonatal circumcision, clinicians should combine sucrose, non-nutritive sucking, and skin-to-skin contact. These low-cost interventions should be bundled into standard procedural protocols.
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
